1999;354:359 364. 178. Maschio G, Alberti D, Janin G, et al. Effect of the angiotensin-converting- enzyme inhibitor benazepril on the progression of chronic renal insuf ciency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insuf ciency Study Group. N Engl J Med. 1996;334: 939 945. 179. Hou FF, Zhang X, Zhang GH, et al. Ef cacy and safety of benazepril for advanced chronic renal insuf ciency. N Engl J Med. 2006;354:131 140. 180. Jafar TH, Stark PC, Schmid CH, et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta- analysis. Ann Intern Med. 2003;139:244 252. 181. Hou FF, Xie D, Zhang X, et al. Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insuf ciency. J Am Soc Nephrol. 2007;18:1889 1898. 182. Hannedouche T, Landais P, Goldfarb B, et al. Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure. BMJ. 1994;309:833 837. 183. Rakugi H, Ogihara T, Umemoto S, et al. Combination therapy for hypertension in patients with CKD: a subanalysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events trial. Hypertens Res. 2013;36:947 958. 184. Esnault VL, Brown EA, Apetrei E, et al. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double- blind, placebo-controlled study. Clin Ther. 2008;30:482 498. 185. Marin IR, Ruilope LM. Effect of antihypertensive treatment on progression of renal insuf ciency in non-diabetics patients (ESPIRAL Trial). Nefrologia. 1995;15:464 475. 186. Zucchelli P, Zuccala A, Borghi M, et al. Long-term comparison between captopril and nifedipine in the progression of renal insuf ciency. Kidney Int. 1992;42:452 458. 187. Woo KT, Choong HL, Wong KS, et al. 